Brimonidine is a drug used as eye drops under the brand names Alphagan and Alphagan-P to treat open-angle glaucoma or ocular hypertension, and as a gel, Mirvaso, for facial skin redness in rosacea. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through ...
Find patient medical information for Brimonidine Ophthalmic (Eye) on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Jan 15, 2016 ... Brimonidine Ophthalmic: learn about side effects, dosage, special precautions, and more on MedlinePlus.
Brimonidine is a drug used to treat glaucoma. It acts via decreasing aqueous humor synthesis. A topical gel formulation, marketed under the name Mirvaso, was FDA approved on August 2013 for the treatment of rosacea.
Learn about Brimonidine (Alphagan P), dosing, proper use and what to know before beginning treatment.
5-bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate; MW= 442.24. In solution, ALPHAGAN® P (brimonidine tartrate ophthalmic solution) has a clear, greenish-yellow color. It has an osmolality of 250-350 mOsmol/kg and a pH of 7.4 -8.0 (0.1%) or 6.6-7.4 (0.15%). Brimonidine tartrate appears as an off-white to ...
Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively lowers IOP and is useful as monotherapy, adjunctive therapy, and replacement therapy in open-angle glaucoma and ocular hypertension. A fixed ...
Brimonidine (Alphagan, Alphagan P - Discontinued in the US) is a drug prescribed for the treatment of open-angle glaucoma. Side effects, drug interactions, and patient safety information is included.
Physician reviewed brimonidine ophthalmic patient information - includes brimonidine ophthalmic description, dosage and directions.